Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Meridian Bioscience Inc (NASDAQ:VIVO)

15.20
Delayed Data
As of 3:59pm ET
 -0.60 / -3.80%
Today’s Change
10.75
Today|||52-Week Range
18.58
-14.12%
Year-to-Date
No recent news for Meridian Bioscience Inc.

Today’s Trading

Previous close15.80
Today’s open15.90
Day’s range14.96 - 15.90
Volume482,103
Average volume (3 months)230,121
Market cap$666.8M
Dividend yield3.29%
Data as of 3:59pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)-10.59%
Earnings growth (this year)-16.25%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.64%
P/E ratio30.4
Price/Sales4.17
Price/Book4.00

Competitors

 Today’s
change
Today’s
% change
CALACalithera Bioscience...-0.55-3.34%
LNTHLantheus Holdings In...0.000.00%
----
OXFDOxford Immunotec Glo...-0.09-0.56%
Data as of 3:59pm ET, 10/23/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)$0.14
Annual revenue (last year)$196.1M
Annual profit (last year)$32.2M
Net profit margin16.44%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John P. Kenny
President &
Chief Commercial Officer
Richard L. Eberly
Corporate headquarters
Cincinnati, Ohio

Forecasts